Nonpharmacologic treatment of hypertension: A multiple-risk-factor approach

Authors
Eileen M. Stuart, RN, MS, Margaret Caudill, MD, PhD, Jane Leserman, PhD, Claudia Darrington, BSc, Richard Friedman, PhD, Herbert Benson, MD
Publication
Journal of Cardiovascular Nursing
1(4):p 1-14
Abstract

Hypertension is one of the leading health problems in the United States. It is commonly accepted that as many as 60 million Americans have hypertension, with the majority (>70%) having mild elevations (diastolic pressure range, 90-104 mm Hg). The treatment of hypertension accounts for more office visits to health care providers and more treatment than any other medical diagnosis. A 1980 National Institutes of Health survey showed that about 2% of visits to health care providers were for the treatment of hypertension. It was also noted that patients with hypertension were more likely (86%) to be treated with medication than were patients with other diseases (63%).

Related Listings
Three Case Reports of the Metabolic and Electro...
Authors
Herbert Benson, M.D., M. S. Malhotra, M.D., Ralph F. Goldman, Ph.D., Gregg D. Jacobs, Ph.D., P. Jeffrey Hopkins, Ph.D.
Journal
Behavioral Medicine
·
To examine the extent to which advanced meditative practices might alter body metabolism and the electroencephalogram (EEG), we investigated three Tibetan Buddhist monks living in the Rumtek monastery in Sikkim, India. In a study carried out in February 1988, we found that during the practice of several different meditative practices, resting metabolism ([Vdot]O2) could be both raised (up to 61%) and lowered (down to 64%). The reduction from rest is the largest ever reported. On the […]
Kundalini Yoga Meditation Versus the Relaxation...
Authors
David Shannahoff-Khalsa, Rodrigo Yacubian Fernandes, Carlos A. de B. Pereira, John S. March, James F. Leckman, Shahrokh Golshan, Mario S.R. Vieira, Guilherme V. Polanczyk, Euripedes C. Miguel, Roseli G. Shavitt
Journal
Frontiers in Psychiatry
Background: Obsessive-compulsive disorder (OCD) is often a life-long disorder with high psychosocial impairment. Serotonin reuptake inhibitors (SRIs) are the only FDA approved drugs, and approximately 50% of patients are non-responders when using a criterion of 25% to 35% improvement with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). About 30% are non-responders to combined first-line therapies (SRIs and exposure and response prevention). Previous research (one open, one randomi […]
Daily Relaxation Response Breaks in a Working P...
Authors
Ruanne K. Peters, Herbert Benson, Douglas Porter
Journal
Am. J. Public Health
·
An experiment conducted at the corporate offices of a manufacturing firm investigated the effects of daily relaxation breaks on five self-reported measures of health, performance, and well-being. For 12 weeks, 126 volunteers filled out daily records and reported bi-weekly for additional measurements. After four weeks of baseline monitoring, they were divided randomly into three groups: Group A was taught a technique for producing the relaxation response; Group B was instructed to sit […]